genOway Shanghai at the Chinese Biopharmaceutical Association meeting 2024

Conference

Event
-
July 3, 2024

The genOway Shanghai team participated in the CBA annual meeting, which hosted over 10,000 attendees, introducing genOway’s preclinical models to the Chinese scientific community.

During the conference, Marième NDJIM, PhD, Senior Business Developer at genOway, delivered an insightful presentation on how the predictability of our models accelerates the development of safer and more effective next-generation drugs.

We are very happy about the collaboration between our teams in France and China and the enthusiasm of all the clients we met.

Other news & events

5th Fc-Mediated Summit 2025, July 29-31, 2025
Conference
genOway presentation
Event
-
Jul 2025
Read on
genOway Shanghai at BIONNOVA West China Forum 2025
Conference
Event
-
Jul 2025
Read on
Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025
Conference
Event
-
Apr 2025
Read on
7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Conference
Event
-
Mar 2025
Read on
NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
Feb 2025
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe